Results 251 to 260 of about 896,459 (312)

Risk of Hepatotoxicity in Patients With Gout Treated With Febuxostat or Benzbromarone: A Propensity Score–Matched Cohort Study

Arthritis Care &Research, EarlyView.
Objective The objective of this study was to evaluate and compare the risk of hepatotoxicity associated with the use of febuxostat and benzbromarone in patients with gout. Methods New users of febuxostat or benzbromarone with monitoring of liver function at least three times in a year after initiation of the study drugs were identified from an ...
Wenyan Sun, Lingling Cui, Robert Terkeltaub, Ying Chen, Xinde Li, Xiaoyu Cheng, Tian Liu, Nicola Dalbeth, Changgui Li   +8 more
wiley   +1 more source

Lack of Pharmacokinetic Drug-Drug Interactions Between Bepirovirsen and Nucleos(t)ide Analogs. [PDF]

Clin Pharmacol Drug Dev
Han K, Youssef AS, Magee M, Hood S, Tracey H, Kwoh J, Theodore D, Paff M, Nader A.   +8 more
europepmc   +1 more source

Approach to Detecting Beneficial and Detrimental Drug-Drug Interactions in Complex Pharmacotherapy. [PDF]

Cureus
Ogura T, Shiraishi C.
europepmc   +1 more source

Assessments of CYP-Inhibition-Based Drug-Drug Interactions Between Tofacitinib and Lipid-Lowering Agents in Rats Both In Vitro and In Vivo. [PDF]

Pharmacol Res Perspect
Yang H, Wang S, Zhou Q, Geng P, Lu Z, Lin Q, Chen C, Zhou Y, Cai J, Dai D.   +9 more
europepmc   +1 more source

The evaluation of potential drug-drug interactions with antibiotics in hospitalized patients. [PDF]

North Clin Istanb
Aydin NN, Aydin M.
europepmc   +1 more source

Improving the Working Models for Drug-Drug Interactions: Impact on Preclinical and Clinical Drug Development. [PDF]

Pharmaceutics
Nguyen J, Joseph D, Chen X, Armanios B, Sharma A, Stopfer P, Huang F.   +6 more
europepmc   +1 more source

Development and Validation of an Approach to Assessing Clinical Relevance of Potential Drug-Drug Interactions Inducing Rare but Serious Adverse Events. [PDF]

Clin Transl Sci
Song M, Zhou H, Yang Z, Lai Y, Ung COL, Hu H.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Drug–drug interaction with statins

Expert Review of Clinical Pharmacology, 2008
3-hydroxy-3-methyl-glutaryl (HMG)-CoA reductase inhibitors (the so-called statins: atorvastatin, fluvastatin, pravastatin, lovastatin, rosuvastatin and simvastatin) are a well-established class of drugs in the treatment of hypercholesterolemia. Statin monotherapy is generally well tolerated, with a low frequency of adverse events.
A. Corsini, S. Bellosta
openaire   +3 more sources

A drug-to-drug interaction package

Computer Methods and Programs in Biomedicine, 1989
This paper describes an electronic database for handling the interactions between active principles administered to various patients. The computer used is a personal computer with adequate mass memory, software, and data obtained from pharmacological sources.
PINCIROLI, FRANCESCO, POZZI, GIUSEPPE
openaire   +4 more sources